Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India
Open Access
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 80 (5) , e71
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquineAnnals of the Rheumatic Diseases, 2020
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitroCell Discovery, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020